Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

1 Super Value Stock Down 30% to Buy in 2024


There's a disconnect between AT (NYSE: T) the stock and AT the company. While investors have punished the telecom stock over the past few years, sending shares down about 30% since the start of 2021, the company itself has been doing just fine. Mostly free from its failed adventure in the media industry, AT is now focused on its wireless and fiber internet businesses.

While AT's pace of subscriber wins fluctuates quarter to quarter and has slowed down as the state of the economy has taken a toll on consumers, zooming out and looking AT the past two years paints a clear picture. The total number of subscribers and connections on AT's wireless network has risen by 20% between September 2021 and September 2023 to about 236 million.

The number of postpaid subscribers has jumped 7.6% in that time to 86.4 million, while the number of connected devices has soared 35% to 122.7 million. The prepaid subscriber count has grown slightly, as has the reseller subscriber count.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,057 €
-0,87 %
Heute erleidet Allergy Therapeutics PLC einen kleinen Verlust von -0,87 %.

Like: 0
T
Teilen

Kommentare